Saito, Takeshi
,
Hatta, Yoshihiro
Hayakawa, Fumihiko
Takahashi, Tsutomu
Hagihara, Maki
Iida, Hiroatsu
Minauchi, Koichiro
Yamazaki, Etsuko
Sugiura, Isamu
Murayama, Tohru
Sakura, Toru
Mori, Naoki
Imai, Kiyotoshi
Yahagi, Yuichi
Atsuta, Yoshiko
Saito, Akiko Moriya
Hirakawa, Akihiro
Kiyoi, Hitoshi
Matsumura, Itaru
Miyazaki, Yasushi
Funding for this research was provided by:
Japan Agency for Medical Research and Development (Grant Number JP19ck0106331)
Article History
Received: 25 August 2020
Revised: 24 October 2020
Accepted: 27 October 2020
First Online: 23 November 2020
Compliance with ethical standards
:
: Hitoshi Kiyoi reports research funding from Chugai Pharmaceutical, Kyowa Kirin, Zenyaku Kogyo, FUJIFILM, Daiichi Sankyo, Astellas Pharma, Otsuka Pharmaceutical, Nippon Shinyaku, Eisai, Pfizer Japan, Takeda Pharmaceutical, Novartis Pharma, Sumitomo Dainippon Pharma, Sanofi, Perseus Proteomics and Celgene, and consulting fees from Astellas Pharma, Amgen Astellas BioPharma, and Daiichi Sankyo, and honoraria from Bristol-Myers Squibb, Astellas Pharma, and Novartis Pharma. Yasushi Miyazaki reports research funding from Sumitomo Dainippon Pharma, Pfizer Japan, Chugai Pharmaceutical, and Takeda Pharmaceutical, and honoraria from Chugai Pharmaceutical, Kyowa Kirin, Astellas Pharma, Otsuka Pharmaceutical, Nippon Shinyaku, Novartis Pharma, Sumitomo Dainippon Pharma, and Celgene. Other authors declare that they have no conflict of interest.